Find a Clinical Trial
Filter
A Study of Sargramostim Plus Pembrolizumab With or Without Pemetrexed in Patients With Advance Non-small Cell Lung Cancer After Completion of Chemoimmunotherapy
Non-small cell lung cancer
All genders
18+
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Division of Thoracic Surgery
A Study of Dato-DXd Versus Investigator's Choice Chemotherapy
All genders
18+
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
Breast Cancer Database
Breast cancer
All genders
18+
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
An Observational Study of Patients Receiving T-DXd for Treatment of HER2+, and HER2-low Unresectable and/or Metastatic Breast Cancer
Breast cancer
All genders
16+
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
Lung CA Dental
Non-small cell lung cancer
All genders
45+
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
HER2 Negative Breast Cancer
Breast cancer
All genders
18+
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Breast cancer
All genders
18+
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center